UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The American journal of clinical nutrition, ISSN 0002-9165, 01/2008, Volume 87, Issue 1, pp. 114 - 125
Randomized controlled clinical trial | Carbohydrate | Diabetes | Diet | Monounsaturated fat | Humans | Life Sciences & Biomedicine | Nutrition & Dietetics | Science & Technology | Fundamental and applied biological sciences. Psychology | Feeding. Feeding behavior | Biological and medical sciences | Vertebrates: anatomy and physiology, studies on body, several organs or systems | Dietary Carbohydrates - administration & dosage | Glycated Hemoglobin A - analysis | Area Under Curve | Glycemic Index | Cholesterol - blood | Middle Aged | Dietary Carbohydrates - classification | Diabetes Mellitus, Type 2 - diet therapy | Male | Dietary Carbohydrates - metabolism | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | C-Reactive Protein - metabolism | Lipids - blood | Dietary Fats - administration & dosage | Cholesterol, HDL - blood | Adult | Female | Aged | Blood Glucose - metabolism | Type 2 diabetes | Carbohydrates | Diet therapy | Research | Cholesterol, HDL | Health aspects | Proteins | Clinical trials | Hemoglobin | Effects | Index Medicus | Abridged Index Medicus
Journal Article
Journal of bone and mineral research, ISSN 0884-0431, 01/2015, Volume 30, Issue 1, pp. 3 - 23
OSTEONECROSIS OF THE JAW | DIAGNOSIS | BISPHOSPHONATES | MANAGEMENT | RISK FACTORS | DENOSUMAB | IMAGING | TREATMENT | Treatment | Imaging | Osteonecrosis of the jaw | Diagnosis | Management | Denosumab | Bisphosphonates | Risk factors | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Humans | Osteoporosis - diagnosis | Osteoporosis - drug therapy | Mandible - diagnostic imaging | Monocytes - immunology | Cone-Beam Computed Tomography | Bisphosphonate-Associated Osteonecrosis of the Jaw - immunology | Mandible - immunology | Bacterial Infections - immunology | Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnostic imaging | Osteoporosis - diagnostic imaging | Monocytes - pathology | Diphosphonates - therapeutic use | T-Lymphocytes - pathology | Diphosphonates - adverse effects | Macrophages - immunology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Osteoporosis - immunology | Macrophages - pathology | Risk Factors | Receptors, Antigen, T-Cell, gamma-delta - immunology | Consensus | Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnosis | Bisphosphonate-Associated Osteonecrosis of the Jaw - therapy | T-Lymphocytes - immunology | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Care and treatment | Bacterial infections | Platelet-derived growth factor | Corticosteroids | Diagnostic imaging | Transplantation | T cells | Necrosis | Osteoporosis | Toiletries industry | Stem cells | Bones | Health aspects | Scanning devices | Index Medicus
Journal Article
Canadian Medical Association journal, ISSN 0008-4409, 11/2002, Volume 167, Issue 90100, pp. S1 - S34
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Phytoestrogens | Bone Density | Prognosis | Osteoporosis - prevention & control | Estrogens, Non-Steroidal | Humans | Middle Aged | Osteoporosis - diagnosis | Risk Factors | Male | Osteoporosis - drug therapy | Randomized Controlled Trials as Topic | Canada | Diet | Plant Preparations | Diphosphonates - therapeutic use | Adult | Female | Aged | Child | Isoflavones | Practice Guidelines as Topic | Osteoporosis | Management | Medical diagnosis | Standards | Index Medicus | Abridged Index Medicus | Supplement
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 232 - 242
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Triazoles - adverse effects | Double-Blind Method | Follow-Up Studies | Administration, Oral | Humans | Kaplan-Meier Estimate | Hospitalization - statistics & numerical data | Pyrazines - therapeutic use | Cardiovascular Diseases - complications | Diabetes Mellitus, Type 2 - blood | Heart Diseases - etiology | Heart Diseases - epidemiology | Pyrazines - adverse effects | Cardiovascular Diseases - mortality | Sitagliptin Phosphate | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Heart Failure - etiology | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Triazoles - therapeutic use | Type 2 diabetes | Care and treatment | Usage | Clinical trials | Influence | Sitagliptin | Dosage and administration | Cardiovascular diseases | Myocardial infarction | Cerebral infarction | Stroke | Inhibitor drugs | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Side effects | Pancreatic cancer | Hemoglobin | Diabetes | Health risk assessment | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article